Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation

NCT07176325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-09-16

No results posted yet for this study

Summary

This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.

Conditions

  • Side Effects of Creatine Monohydrate Dosing

Interventions

OTHER

Creatine Monohydrate

Creatine Monohydrate was dosed based on industry recommendations, with and without a loading dose

Sponsors & Collaborators

  • Vireo Systems, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-30
Primary Completion
2024-07-03
Completion
2024-07-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07176325 on ClinicalTrials.gov